Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists.

Authors	Massimo Volpe, Giovanna Gallo
Journal	Cardiovascular research (Cardiovasc Res) Vol. 117 Issue 9 Pg. 1992-1994 (07 27 2021) ISSN: 1755-3245 [Electronic] England
PMID	33231613 (Publication Type: Editorial, Comment)
Chemical References	Glucagon-Like Peptide Receptors Glucagon-Like Peptide-1 Receptor Sodium-Glucose Transporter 2 Inhibitors Symporters Sodium Glucose
Topics	Glucagon-Like Peptide Receptors Glucagon-Like Peptide-1 Receptor (metabolism) Glucose Heart Failure (drug therapy) Humans Phenotype Sodium Sodium-Glucose Transporter 2 Inhibitors Stroke Volume Symporters

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!